Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 29: 1474-1479, 1983;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weeks, I.
Right arrow Articles by Woodhead, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weeks, I.
Right arrow Articles by Woodhead, J. S.

Clinical Chemistry, Vol 29, 1474-1479, Copyright © 1983 by American Association for Clinical Chemistry

Acridinium esters as high-specific-activity labels in immunoassay

I Weeks, I Beheshti, F McCapra, AK Campbell and JS Woodhead

A chemiluminescent acridinium ester has been synthesized that reacts spontaneously with proteins to yield stable, immunoreactive derivatives of high specific activity. The compound has been used to prepare chemiluminescent monoclonal antibodies to human alpha 1-fetoprotein having average incorporation ratios as great as 2.8 mol of label per mole of antibody, which corresponds to a detection limit of approximately 8 X 10(-19) mol. These antibodies have been used in the preliminary development of a two-site immunochemiluminometric assay for human alpha 1-fetoprotein, which requires only a 30-min incubation and a quantification time of 5 s per sample.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Pandian, J. Lu, and J. Ossolinska-Plewnia
Fully Automated Chemiluminometric Assay for Hyperglycosylated Human Chorionic Gonadotropin (Invasive Trophoblast Antigen)
Clin. Chem., May 1, 2003; 49(5): 808 - 810.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. G. Klee, M. K. Goodmanson, S. J. Jacobsen, C. Y.F. Young, J. A. Finlay, H. G. Rittenhouse, R. L. Wolfert, and D. J. Tindall
Highly Sensitive Automated Chemiluminometric Assay for Measuring Free Human Glandular Kallikrein-2
Clin. Chem., June 1, 1999; 45(6): 800 - 806.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. S. McConnell, Q. Wang, P. M. Sluss, N. Bolf, R. H. Khoury, A. L. Schneyer, A. R. Midgley Jr., N. E. Reame, W. F. Crowley Jr., and V. Padmanabhan
A Two-Site Chemiluminescent Assay for Activin-Free Follistatin Reveals That Most Follistatin Circulating in Men and Normal Cycling Women Is in an Activin-Bound State
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 851 - 858.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
D. J. O'Kane, T. A. Ebert, B. J. Hallaway, S. G. Roberts, A. K. M. J. Bhuiyan, and K. S. Tenner
A laboratorian's perspective on evaluation and implementation of new laboratory tests
Clin. Chem., September 1, 1997; 43(9): 1771 - 1780.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Association for Clinical Chemistry.